impact of adding bevacizumab to presurgery chemo for 3n bc varies with subtype
Published 9 years ago • 19 plays • Length 8:51Download video MP4
Download video MP3
Similar videos
-
9:50
impact of adding bevacizumab to presurgery chemo for 3n bc varies with subtype
-
1:54
comment: impact of combined bevacizumab and presurgery chemo varies by subtype
-
6:37
atezolizumab versus placebo in combination with bevacizumab and non-platinum-based chemotherapy ...
-
10:05
exploring systemic therapy before breast cancer surgery: what you need to know
-
1:09
how immunotherapy is changing cancer treatments
-
2:24
how targeted therapy avastin (bevacizumab) treats metastatic cancer
-
1:52
safety of bca101, an egfr/tgfβ inhibitor, with pembrolizumab in hnscc
-
0:54
celebrate: carboplatin, etoposide, bevacizumab and atezolizumab in extensive-stage sclc
-
5:27
how can breast cancer treatment impact your fertility? expert insights
-
0:40
beat-meso: phase iii trial of bevacizumab and chemo ± atezolizumab for advanced pleural mesothelioma
-
3:13
side effects of targeted agents in colorectal cancer
-
6:20
dose-dense chemotherapy for ovarian cancer; adding bevacizumab
-
0:23
adding avastin to chemo in metastatic colon cancer
-
1:24
bevacizumab improves efficacy of trifluridine/tipiracil (tas-102) in patients with chemorefracto...
-
1:06
dr. krishnansu tewari on bevacizumab in advanced cervical cancer
-
1:19
dr. essel discusses adverse events of bevacizumab in ovarian cancer
-
0:35
dr. brufsky discusses bevacizumab benefits in tnbc
-
9:03
paclitaxel for breast cancer: side effects, benefits, and what to expect
-
3:47
gog-0218: which patients with ovarian cancer experience highest benefit from 1l bevacizumab?